Hospital
Citrus Hma INC
Citrus Hma INC was paid $6.38M by Medicaid between Jan 2018 and Oct 2023, across 120 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoCITRUS HMA INC
CRYSTAL RIVER, FL 34428
CRYSTAL RIVER, FL 34428
33aNPI1336386457assigned 01/12/2009
33bProvider typeRehabilitation Hospital Unit
28Total paid$6.38M
24GClaims210,097
24DCodes billed120
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other Rehabilitation Hospital Unit providers in Florida
Rank by total paid#8 of 11
Median peer was paid$15.92M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,764 | $160K | |
| 2019 | 36,857 | $817K | |
| 2020 | 35,566 | $789K | |
| 2021 | 56,375 | $1.64M | |
| 2022 | 47,906 | $1.98M | |
| 2023 | 20,629 | $992K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 20,309 | 18,206 | $1.87M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 12,934 | 11,177 | $868K |
| 36415 | Collection of venous blood by venipuncture | 9.3% | 13,467 | 10,149 | $593K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.3% | 5,553 | 5,093 | $465K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.2% | 2,205 | 1,947 | $458K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.2% | 3,191 | 2,647 | $395K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.1% | 1,629 | 1,476 | $388K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.3% | 4,265 | 3,651 | $340K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.3% | 4,960 | 4,242 | $209K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,978 | 1,414 | $97K |
| 80053 | Comprehensive metabolic panel | <1% | 12,011 | 9,985 | $55K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,275 | 1,003 | $45K |
108 more codes
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 833 | $43K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,011 | $38K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 99 | $32K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 3,709 | $31K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 211 | $28K |
| 86900 | <1% | 271 | $28K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,786 | $27K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,321 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,435 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,696 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,878 | $19K |
| 81003 | <1% | 5,587 | $16K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,019 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 214 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,068 | $14K |
| 73630 | <1% | 562 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,940 | $13K |
| 81025 | <1% | 2,366 | $11K | |
| 73610 | <1% | 580 | $10K | |
| 83880 | <1% | 1,292 | $9K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 113 | $9K |
| 81001 | <1% | 4,876 | $8K | |
| 73110 | <1% | 269 | $7K | |
| 73562 | <1% | 396 | $6K | |
| 73130 | <1% | 357 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 110 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 407 | $6K |
| 87070 | <1% | 298 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,895 | $6K |
| 82962 | <1% | 954 | $5K | |
| 85610 | <1% | 4,578 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,246 | $5K |
| 85730 | <1% | 3,149 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 97 | $4K |
| 73030 | <1% | 269 | $4K | |
| 97597 | <1% | 32 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 617 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,125 | $4K |
| 84484 | <1% | 3,575 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,198 | $3K |
| 85651 | <1% | 36 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 786 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 25 | $3K |
| 83735 | <1% | 4,059 | $3K | |
| 72131 | <1% | 109 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,686 | $3K |
| 83690 | <1% | 3,663 | $2K | |
| 59025 | Fetal non-stress test | <1% | 27 | $2K |
| 85027 | <1% | 107 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,877 | $2K |
| 12001 | <1% | 74 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 722 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,290 | $2K |
| 87186 | <1% | 1,170 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 74 | $2K |
| 87040 | <1% | 1,042 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 764 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 356 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,755 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 908 | $1K |
| 71250 | <1% | 28 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 343 | $1K |
| 83605 | <1% | 571 | $840.35 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 992 | $828.57 |
| 93971 | <1% | 27 | $734.79 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,335 | $721.80 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 397 | $673.62 |
| 85379 | <1% | 486 | $585.18 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 32 | $532.35 |
| 12002 | <1% | 12 | $524.52 | |
| 87807 | <1% | 467 | $457.80 | |
| 82248 | <1% | 611 | $396.53 | |
| 74018 | <1% | 72 | $385.02 | |
| 84702 | <1% | 536 | $380.79 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 539 | $338.30 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 243 | $287.94 |
| 90714 | <1% | 217 | $274.14 | |
| 82150 | <1% | 541 | $225.14 | |
| 82550 | <1% | 319 | $211.57 | |
| 84703 | <1% | 729 | $153.26 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 231 | $151.52 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 118 | $134.95 |
| 82077 | <1% | 643 | $116.01 | |
| 96376 | <1% | 99 | $108.43 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 483 | $101.36 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 254 | $73.88 |
| 86850 | <1% | 38 | $51.89 | |
| 84100 | <1% | 56 | $43.82 | |
| 86901 | <1% | 212 | $43.72 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 243 | $42.50 |
| 72100 | <1% | 30 | $37.87 | |
| 86140 | <1% | 124 | $36.54 | |
| 80061 | Lipid panel | <1% | 36 | $10.58 |
| 80143 | <1% | 202 | $6.76 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $6.26 |
| 87430 | <1% | 482 | $4.55 | |
| 73502 | 0% | 13 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 18 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 12 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 12 | $0.00 |
| 86403 | 0% | 20 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 15 | $0.00 |
| 80179 | 0% | 219 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 12 | $0.00 |
| 73080 | 0% | 64 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 176 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 13 | $0.00 |
| 80076 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.